Additional Bonus Compensation. For each calendar year in which Employer’s EBITDA projections for Acquired Products are exceeded by 25% or more, Employer may pay Employee, within 90 days after the end of that year, an additional bonus (“Additional Bonus Compensation”) in a target amount of $175,000 (less all required tax withholding), provided that the Board is otherwise satisfied with the performance of both the Employee and the Employer. The foregoing notwithstanding, subject to the approval of the Employee (which shall not be unreasonably withheld or delayed), the criteria for each of the bonuses described in this Section 2(c) may be modified from time to time by the Board to include alternate targets and milestones.
Appears in 2 contracts
Sources: Employment Agreement (Reliant Pharmaceuticals, Inc.), Employment Agreement (Reliant Pharmaceuticals, Inc.)